Multinational pharmaceutical companies will expand more investment of R&D despite bad business situa

Published: 2013-12-24 06:58:00

Updated: 2013-12-24 06:58:00

Multinational pharmaceutical companies will expand more investment of R&D despite bad business situation.

KRPIA announced the research result of local R&D in 2012.
(Yakup Shinmoon)

Despite stagnation of local pharmaceutical industry in 2012 because of stronger regulation by government such as lump-sum drug price reduction, multinational pharmaceutical companies have invested more to R&D in...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.